Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hereditary thrombophilia as a possible risk factor for severe disease in COVID-19: a case series.

Forensic science, medicine, and pathology - 1 Mar 2025

Tse Jonathan, Gongolli Julita, Prahlow Joseph A

Abstract excerpt

PURPOSE: The risk factors that modulate one's susceptibility for severe COVID-19 have been well documented. Despite this, hypercoagulability remains an often overlooked risk factor for severe disease for COVID-19. Because COVID-19 infection is a risk factor for hypercoagulability, a reasonable presumption/hypothesis is that patients with hereditary thrombophilia would be at a higher risk of thrombotic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fatal Outcome
Share to Methylenetetrahydrofolate Reductase (NADPH2)

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myocardial Infarction

Share to Plasminogen Activator Inhibitor 1

Share to Pulmonary Embolism

Share to SARS-CoV-2

Share to Thrombophilia

Share to Venous Thrombosis

Source

Identifiers

PMID: 39331315
DOI: 10.1007/s12024-024-00879-4

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hereditary thrombophilia as a possible risk factor for severe disease in COVID-19: a case series.PMID 39331315Read ↗

Contribution of genotypes in Prothrombin and Factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia.Semantic proximity Read ↗

Thrombophilia genetic mutations and their relation to disease severity among patients with COVID-19.Semantic proximity Read ↗

Effect of Hereditary Thrombophilia on the Clinical Severity of Covid-19 PneumoniaSemantic proximity Read ↗

Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review.Semantic proximity Read ↗

Thrombosis Risk Assessment in Patients with Congenital Thrombophilia During COVID-19 InfectionSemantic proximity Read ↗

The effect of hereditary thrombotic factors and comorbidities on the severity of COVID-19 disease.Semantic proximity Read ↗

Genome-wide cross-trait analysis and Mendelian randomization reveal a shared genetic etiology and causality between COVID-19 and venous thromboembolismSemantic proximity Read ↗

Shared genetic etiology and causality between COVID-19 and venous thromboembolism: evidence from genome-wide cross trait analysis and bi-directional Mendelian randomization studySemantic proximity Read ↗

Polygenic predisposition to venous thromboembolism is associated with increased COVID-19 positive testing ratesSemantic proximity Read ↗

Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidenceSemantic proximity Read ↗

Thromboembolic Events in Deceased Patients with Proven SARS-CoV-2 Infection: Frequency, Characteristics and Risk FactorsSemantic proximity Read ↗

Thromboembolic risk in hospitalised and non-hospitalised Covid-19 patients: A self-controlled case series analysis of a nation-wide cohortSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.